Cargando…

ZHX2 in health and disease

As a transcriptional factor and the negative regulator of alpha fetal protein (AFP), Zinc fingers and homeoboxes 2 (ZHX2) has a well-established role in protection against hepatocellular carcinoma (HCC). However, recent studies have suggested ZHX2 as an oncogene in clear cell renal cell carcinoma (c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Na, Wu, Zhuanchang, Ma, Chunhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9718504/ https://www.ncbi.nlm.nih.gov/pubmed/36465389 http://dx.doi.org/10.3389/fonc.2022.1038890

Ejemplares similares

Transcription factor Zhx2 restricts NK cell maturation and suppresses their antitumor immunity
por: Tan, Siyu, et al.
Publicado: (2021)

Zhx2 maintains islet β-cell mass and function by transcriptionally regulating Pax6
por: Ding, Lu, et al.
Publicado: (2023)

Tumor suppressor ZHX2 inhibits NAFLD–HCC progression via blocking LPL-mediated lipid uptake
por: Wu, Zhuanchang, et al.
Publicado: (2019)

ZHX2 emerges as a negative regulator of mitochondrial oxidative phosphorylation during acute liver injury
por: Zhang, Yankun, et al.
Publicado: (2023)

Low expression of ZHX1 and ZHX2 impacts on the prognosis of chronic lymphocytic leukemia
por: Maciel, Natália Ioseph Gladistone, et al.
Publicado: (2021)

ZHX2 restricts hepatocellular carcinoma by suppressing stem cell-like traits through KDM2A-mediated H3K36 demethylation
por: Lin, Qinghai, et al.
Publicado: (2020)

ZHX2 inhibits thyroid cancer metastasis through transcriptional inhibition of S100A14
por: Zhang, Yankun, et al.
Publicado: (2022)

ZHX2 enhances the cytotoxicity of chemotherapeutic drugs in liver tumor cells by repressing MDR1 via interfering with NF-YA
por: Ma, Hongxin, et al.
Publicado: (2014)

N-Glycosylation at Asn291 Stabilizes TIM-4 and Promotes the Metastasis of NSCLC
por: Chen, Siyuan, et al.
Publicado: (2022)

USP13 promotes deubiquitination of ZHX2 and tumorigenesis in kidney cancer
por: Xie, Haibiao, et al.
Publicado: (2022)

ZHX2 is a repressor of α-fetoprotein expression in human hepatoma cell lines
por: Shen, H, et al.
Publicado: (2008)

ZHX1 Promotes the Proliferation, Migration and Invasion of Cholangiocarcinoma Cells
por: Kwon, Ryuk-Jun, et al.
Publicado: (2016)

ZHX2 deficiency enriches hybrid MET cells through regulating E-cadherin expression
por: He, Yan, et al.
Publicado: (2023)

Upregulation of ZHX2 predicts poor prognosis and is correlated with immune infiltration in gastric cancer
por: Cheng, Anqi, et al.
Publicado: (2021)

Low expression of ZHX3 is associated with progression and poor prognosis in colorectal cancer
por: Cai, Zhai, et al.
Publicado: (2023)

ZHX2 promotes HIF1α oncogenic signaling in triple-negative breast cancer
por: Fang, Wentong, et al.
Publicado: (2021)

ZHX1 Inhibits Gastric Cancer Cell Growth through Inducing Cell-Cycle Arrest and Apoptosis
por: Ma, Xingjie, et al.
Publicado: (2016)

ZHX3 promotes the progression of urothelial carcinoma of the bladder via repressing of RGS2 and is a novel substrate of TRIM21
por: Deng, Minhua, et al.
Publicado: (2021)

Attenuated ZHX3 expression is predictive of poor outcome for liver cancer: Indication for personalized therapy
por: You, Yanjie, et al.
Publicado: (2022)

Attenuated ZHX3 expression serves as a potential biomarker that predicts poor clinical outcomes in breast cancer patients
por: You, Yanjie, et al.
Publicado: (2019)

ZHX2 mediates proteasome inhibitor resistance via regulating nuclear translocation of NF‐κB in multiple myeloma
por: Jiang, Jifeng, et al.
Publicado: (2020)

Novel VHL substrate targets SFMBT1 and ZHX2 may be important prognostic predictors in patients with ccRCC
por: Chen, Yufeng, et al.
Publicado: (2021)

Loss of the transcription repressor ZHX3 induces senescence-associated gene expression and mitochondrial-nucleolar activation
por: Igata, Tomoka, et al.
Publicado: (2022)

Cooperative regulation of Zhx1 and hnRNPA1 drives the cardiac progenitor-specific transcriptional activation during cardiomyocyte differentiation
por: Chen, Yang, et al.
Publicado: (2023)

Novel structural features in two ZHX homeodomains derived from a systematic study of single and multiple domains
por: Bird, Louise E, et al.
Publicado: (2010)

Blocking lncRNA MALAT1/miR-199a/ZHX1 Axis Inhibits Glioblastoma Proliferation and Progression
por: Liao, Keman, et al.
Publicado: (2019)

Palmitoylation of SARS-CoV-2 S protein is essential for viral infectivity
por: Wu, Zhuanchang, et al.
Publicado: (2021)

SREBF2–STARD4 axis confers sorafenib resistance in hepatocellular carcinoma by regulating mitochondrial cholesterol homeostasis
por: Yue, Xuetian, et al.
Publicado: (2022)

HNRNPD interacts with ZHX2 regulating the vasculogenic mimicry formation of glioma cells via linc00707/miR-651-3p/SP2 axis
por: Yu, Sifei, et al.
Publicado: (2021)

LncRNA LINC01140 Inhibits Glioma Cell Migration and Invasion via Modulation of miR-199a-3p/ZHX1 Axis
por: Xin, Yanchao, et al.
Publicado: (2020)

ZHX2 drives cell growth and migration via activating MEK/ERK signal and induces Sunitinib resistance by regulating the autophagy in clear cell Renal Cell Carcinoma
por: Zhu, Liangsong, et al.
Publicado: (2020)

Systemic Inflammation Response Index Is a Predictor of Poor Survival in Locally Advanced Nasopharyngeal Carcinoma: A Propensity Score Matching Study
por: Feng, Yuhua, et al.
Publicado: (2020)

Peptide targeting the interaction of S protein cysteine-rich domain with Ezrin restricts pan-coronavirus infection
por: Wu, Zhuanchang, et al.
Publicado: (2023)

Correction: ZHX2 drives cell growth and migration via activating MEK/ERK signal and induces Sunitinib resistance by regulating the autophagy in clear cell Renal Cell Carcinoma
por: Zhu, Liangsong, et al.
Publicado: (2021)

Characterization of circSEC11A as a novel regulator of Iodine-125 radioactive seed-induced anticancer effects in hepatocellular carcinoma via targeting ZHX2/GADD34 axis
por: Li, Dong, et al.
Publicado: (2023)

Lipophagy-mediated cholesterol synthesis inhibition is required for the survival of hepatocellular carcinoma under glutamine deprivation
por: Kong, Youzi, et al.
Publicado: (2023)

Anticancer Mechanisms of Salinomycin in Breast Cancer and Its Clinical Applications
por: Wang, Hui, et al.
Publicado: (2021)

Evaluation of PD-L1 Expression Level in Patients With Non-Small Cell Lung Cancer by (18)F-FDG PET/CT Radiomics and Clinicopathological Characteristics
por: Li, Jihui, et al.
Publicado: (2021)

Utility of Clinical–Radiomic Model to Identify Clinically Significant Prostate Cancer in Biparametric MRI PI-RADS V2.1 Category 3 Lesions
por: Jin, Pengfei, et al.
Publicado: (2022)

A Nomogram Combined Radiomics and Clinical Features as Imaging Biomarkers for Prediction of Visceral Pleural Invasion in Lung Adenocarcinoma
por: Zha, Xinyi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4i0fjcvjr4skag8o50diie32gh